• Two immune checkpoint inhibitors efficiently block leukemia development in preclinical tests

    One year ago - By News Medical

    Chronic lymphocytic leukemia is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream.
    Read more ...


  • Efficient control of leukemia with treatment by dual immune-checkpoint blockade

    One year ago - By ScienceDaily

    Chronic lymphocytic leukemia is a hematological malignancy. When infiltrating tissues, CLL cells come in contact with healthy cells, including immune cells. Researchers have now characterized the composition of immune cells and circulating cytokines of the CLL microenvironment in mouse models using mass cytometry. Based on this knowledge, they propose an immunotherapeutic strategy with two immune checkpoint inhibitors that efficiently blocks disease development in preclinical tests.
    Read more ...